|
140
|
329
|
6fetA |
Crystal structure of human phosphodiesterase 4d2 catalytic domain with inhibitor npd-1439 |
|
139
|
333
|
6fe3A |
Crystal structure of t. brucei pde-b1 catalytic domain with inhibitor npd-1439 |
|
139
|
330
|
6fe7A |
Crystal structure of human phosphodiesterase 4d2 catalytic domain with inhibitor npd-356 |
|
132
|
329
|
6ftaA |
Crystal structure of human phosphodiesterase 4d2 catalytic domain with inhibitor npd-3098 |
|
130
|
333
|
6ftmA |
Crystal structure of t. brucei pde-b1 catalytic domain with inhibitor npd-048 |
|
137
|
325
|
6febA |
Crystal structure of human phosphodiesterase 4d2 catalytic domain with inhibitor npd-1086 |
|
134
|
329
|
6ft0A |
Crystal structure of human phosphodiesterase 4d2 catalytic domain with inhibitor npd-425 |
|
140
|
331
|
6ftwA |
Crystal structure of human phosphodiesterase 4d2 catalytic domain with inhibitor npd-048 |
|
113
|
324
|
6ijiA |
Crystal structure of pde10 in complex with inhibitor 2b |
|
131
|
333
|
6fdxA |
Crystal structure of t. brucei pde-b1 catalytic domain with inhibitor npd-1086 |
|
136
|
333
|
6fv9A |
Crystal structure of t. brucei pde-b1 catalytic domain with inhibitor npd-007 |
|
143
|
330
|
6fdiA |
Crystal structure of human phosphodiesterase 4d2 catalytic domain with inhibitor npd-226 |
|
122
|
322
|
6ijhA |
Crystal structure of pde10 in complex with inhibitor af-399/14387019 |
|
138
|
333
|
6fdsA |
Crystal structure of t. brucei pde-b1 catalytic domain with inhibitor npd-226 |
|
133
|
333
|
6fdwA |
Crystal structure of t. brucei pde-b1 catalytic domain with inhibitor npd-356 |
|
139
|
329
|
6fw3A |
Crystal structure of human phosphodiesterase 4d2 catalytic domain with inhibitor npd-007 |
|
130
|
322
|
6a3nA |
Crystal structure of the pde9 catalytic domain in complex with inhibitor 2 |
|
127
|
324
|
3tgeA |
A novel series of potent and selective pde5 inhibitor1 |
|
127
|
324
|
3tggA |
A novel series of potent and selective pde5 inhibitor2 |
|
125
|
326
|
6acbA |
Crystal structure of pde5 in complex with inhibitor lw1805 |
|
135
|
333
|
5l9hA |
Crystal structure of t. brucei pde-b1 catalytic domain with inhibitor npd-340 |
|
135
|
333
|
5l8cA |
Crystal structure of t. brucei pde-b1 catalytic domain with inhibitor npd-039 |
|
137
|
323
|
5k6jA |
Human phospodiesterase 4b in complex with pyridyloxy-benzoxaborole based inhibitor |
|
133
|
325
|
5k1iA |
Pde4 crystal structure in complex with small molecule inhibitor |
|
115
|
312
|
5k9rA |
Pde10a with imidazopyrazine inhibitor |
|
130
|
313
|
5i2rA |
Human pde10a in complex with 3-(2-phenylpyrazol-3-yl)-1-[3-(trifluoromethoxy)phenyl]pyridazin-4-one |
|
137
|
329
|
6fdcA |
Crystal structure of the pde4d catalytic domain in complex with gebr-32a |
|
134
|
322
|
6f8rA |
Crystal structure of the pde4d catalytic domain in complex with gebr-54 |
|
137
|
322
|
6f8xA |
Crystal structure of the pde4d catalytic domain in complex with gebr-26g |
|
130
|
328
|
6f6uA |
Crystal structure of the pde4d catalytic domain in complex with gebr-7b |
|
134
|
322
|
6f8uA |
Crystal structure of the pde4d catalytic domain in complex with gebr-20b |
|
135
|
328
|
6f8tA |
Crystal structure of the pde4d catalytic domain in complex with gebr-4a |
|
134
|
327
|
6f8vA |
Crystal structure of the pde4d catalytic domain in complex with gebr-18b |
|
132
|
322
|
6f8wA |
Crystal structure of the pde4d catalytic domain in complex with gebr-18a |
|
140
|
342
|
6ezfA |
Pde2 in complex with molecule 5 |
|
135
|
352
|
6cycA |
Pde2 in complex with compound 5 |
|
132
|
352
|
6cydA |
Pde2 in complex with compound 7 |
|
134
|
352
|
6cybA |
Pde2 in complex with compound 7 |
|
140
|
339
|
6c7fA |
Crystal structure of human phosphodiesterase 2a with 1-(2-chloro-5-isobutoxy-phenyl)-n,4-dimethyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide |
|
135
|
342
|
6c7dA |
Crystal structure of human phosphodiesterase 2a with n-(1-adamantyl)-1-(2-chlorophenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide |
|
137
|
342
|
6c7eA |
Crystal structure of human phosphodiesterase 2a with 1-(2-chlorophenyl)-n,4-dimethyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide |
|
136
|
342
|
6c7jA |
Crystal structure of human phosphodiesterase 2a with 1-(5-tert-butoxy-2-chloro-phenyl)-n-isobutyl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide |
|
136
|
342
|
6c7iA |
Crystal structure of human phosphodiesterase 2a with 1-(2-chloro-5-methoxy-phenyl)-n-isobutyl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide |
|
133
|
341
|
6c7gA |
Crystal structure of human phosphodiesterase 2a with n-(1-adamantyl)-1-(2-chloro-5-isobutoxy-phenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide |
|
145
|
353
|
6bojA |
Crystal structure of the pde4d catalytic domain and ucr2 regulatory helix with bpn5004 |
|
134
|
352
|
6b97A |
Crystal structure of pde2 in complex with complex 9 |
|
136
|
352
|
6b96A |
Crystal structure of pde2 in complex with compound 16 |
|
130
|
353
|
6b98A |
Pde2 in complex with compound 1 |
|
121
|
326
|
5zz2A |
Crystal structure of pde5 in complex with inhibitor lw1634 |
|
132
|
340
|
5xkmA |
Crystal structure of human phosphodiesterase 2a in complex with 6-methyl-n-(1-(4-(trifluoromethoxy)phenyl)propyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide |
